Gaudium IVF & Women Health
add_icon

Gaudium IVF & Women Health

70.67
-6.37
(-8.27%)
Market Cap
514.38 Cr
PE Ratio
24.72
Volume
6,28,770.00
Day High - Low
77.38 - 69.18
52W High-Low
99.75 - 72.02
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
514.38 Cr
EPS
3.12
PE Ratio
24.72
PB Ratio
3.77
Book Value
20.45
EBITDA
28.90
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
41.31
Debt to Equity
0.52
Forecast For
Actual

Company News

View All News
Caret
positive
Gaudium IVF Claims Growth Potential in India Fertility4 days ago
Gaudium IVF And Women Health positions itself for leadership in India's fertility care sector, focusing on expanding access and improving outcomes through trusted network development.
positive
Gaudium IVF announces Q3 FY26 results with consolidated revenue of ₹245.07 crores and net profit of ₹36.31 crores, marking first earnings post-IPO listing on February 27, 2026.
neutral
Gaudium IVF and Women Health Limited's board approved appointment of Ram Rattan & Associates as Internal Auditors and Suresh Nainwal & Company as Secretarial Auditors for FY 2025-26.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,307.60
#1 21,908.97
41.18
#1 2,554.80
11.28
#1 492
-6.83
35.00
450.20
9,332.10
53.78
1,346.30
10.64
146
33.65
42.72
883.20
9,072.67
58.06
699.70
23.06
144
22.38
29.31
373.30
5,941.51
41.37
702.20
20.80
91
47.37
45.69
501.00
5,027.07
74.84
769.90
33.97
67
60.20
39.09
574.30
1,862.95
23.65
742.70
16.70
78
-21.13
29.51
258.75
1,347.59
41.91
255.90
15.11
31
20.00
44.04
1,224.20
1,050.72
19.12
111.60
28.72
48
65.93
38.12
517.25
1,010.82
#1 17.69
147.80
#1 134.60
19
#1 520.00
35.28
277.10
881.47
30.90
1,170.80
-18.47
-134
101.06
44.36
Growth Rate
Revenue Growth
32.22 %
Net Income Growth
15.06 %
Cash Flow Change
153.49 %
ROE
-17.21 %
ROCE
-15.64 %
EBITDA Margin (Avg.)
-15.34 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
14
27
18
32
25
Expenses
9
18
13
18
18
EBITDA
6
9
5
14
7
Operating Profit %
39 %
33 %
29 %
43 %
27 %
Depreciation
1
0
1
1
1
Interest
0
0
1
1
1
Profit Before Tax
5
8
4
13
5
Tax
1
2
1
3
1
Net Profit
3
7
3
9
4
EPS in ₹
0.55
1.07
0.51
1.53
0.59

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
18
37
57
89
Fixed Assets
4
18
19
18
Current Assets
14
18
38
54
Capital Work in Progress
0
0
0
7
Investments
0
0
0
5
Other Assets
14
18
39
58
Total Equity & Liabilities
18
37
57
89
Current Liabilities
6
10
20
38
Non Current Liabilities
3
4
4
4
Total Equity
9
23
33
46
Reserve & Surplus
8
22
32
16
Share Capital
1
1
1
31

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
14
-3
-5
Investing Activities
-1
-16
-5
-15
Operating Activities
-1
24
3
9
Financing Activities
3
5
-1
2

Share Holding

% Holding
Jan 2025
Sept 2025
Feb 2026
Promoter
99.98 %
99.98 %
71.29 %
FIIs
0.00 %
0.00 %
9.24 %
DIIs
0.00 %
0.00 %
5.11 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
13.52 %
Others
0.02 %
0.02 %
0.84 %
No of Share Holders
7
7
7

Technical Indicators

RSI(14)
Neutral
46.84
ATR(14)
Volatile
6.79
STOCH(9,6)
Oversold
0.00
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Downtrend And Accelerating
-4.63
WillR(14)
Oversold
-81.90